Symmetry Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-484
| Closed | -$232K | – | 583 |
|
|
2023
Q1 | $232K | Sell |
484
-169
| -26% | -$81K | 0.01% | 507 |
|
|
2022
Q4 | $275K | Sell |
653
-243
| -27% | -$102K | 0.02% | 478 |
|
|
2022
Q3 | $374K | Sell |
896
-219
| -20% | -$91.4K | 0.03% | 381 |
|
|
2022
Q2 | $552K | Hold |
1,115
| – | – | 0.04% | 291 |
|
|
2022
Q1 | $628K | Hold |
1,115
| – | – | 0.04% | 308 |
|
|
2021
Q4 | $842K | Hold |
1,115
| – | – | 0.05% | 251 |
|
|
2021
Q3 | $807K | Hold |
1,115
| – | – | 0.05% | 272 |
|
|
2021
Q2 | $718K | Sell |
1,115
-131
| -11% | -$84.4K | 0.05% | 309 |
|
|
2021
Q1 | $712K | Sell |
1,246
-4
| -0.3% | -$2.29K | 0.05% | 287 |
|
|
2020
Q4 | $729K | Buy |
1,250
+1
| +0.1% | +$583 | 0.06% | 259 |
|
|
2020
Q3 | $644K | Buy |
1,249
+323
| +35% | +$167K | 0.05% | 254 |
|
|
2020
Q2 | $418K | Buy |
926
+133
| +17% | +$60K | 0.05% | 183 |
|
|
2020
Q1 | $278K | Buy |
793
+219
| +38% | +$76.8K | 0.06% | 223 |
|
|
2019
Q4 | $212K | Buy |
+574
| New | +$212K | 0.04% | 313 |
|
|
2019
Q3 | – | Sell |
-644
| Closed | -$201K | – | 339 |
|
|
2019
Q2 | $201K | Hold |
644
| – | – | 0.04% | 316 |
|
|
2019
Q1 | $197K | Hold |
644
| – | – | 0.03% | 309 |
|
|
2018
Q4 | $150K | Buy |
+644
| New | +$150K | 0.04% | 296 |
|